These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 5565230)

  • 1. [The lymphocytotoxins].
    Verroust P
    Presse Med (1893); 1971 Jul; 79(33):1485. PubMed ID: 5565230
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of viruses in the aetiology of connective tissue diseases.
    Kalliomäki JL; Halonen P
    Ann Clin Res; 1975 Jun; 7(3):129-37. PubMed ID: 1103710
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphocyte nucleolar activation as a marker of autoimmune disorders. II. Observations in patients with systemic lupus erythematosus and other connective tissue diseases.
    Korcákova L; Pekárek J; Rovenský J; Trnavský K; Lukác J; Haskova V
    Immunology; 1976 Nov; 31(5):803-5. PubMed ID: 992713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human tissue (HL-A) antigens: role in allograft rejection and in collagen vascular diseases.
    Mittal KK
    Indian J Med Sci; 1972 Aug; 26(8):515-21. PubMed ID: 4566865
    [No Abstract]   [Full Text] [Related]  

  • 5. [The collagen diseases. Present pathogenic interpretations].
    Moulias R; Goust JM
    Nouv Presse Med; 1972 May; 1(21):1399-401. PubMed ID: 4402549
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphocytes' cytotoxicity towards cells of human lymphoblastoid lines in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Skurkovich SV; Skorikova AS; Dubrovina NA; Riabova TV; Eremkina EI; Golodnenkova VN; Klinova EG; Olshanski AJ; Shurlapova NF
    Ann Allergy; 1977 Nov; 39(5):344-50. PubMed ID: 921001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology in rheumatology--1975.
    Waxman J
    J La State Med Soc; 1975 Jun; 127(6):203-7. PubMed ID: 239074
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocytotoxic antibodies.
    DeHoratius RJ
    Prog Clin Immunol; 1980; 4():151-54. PubMed ID: 6992218
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pathomechanisms of tissue damage exemplified by collagenoses].
    Kalden JR; Krapf F
    Verh Dtsch Ges Inn Med; 1987; 93():93-7. PubMed ID: 3502054
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of antigen specific T-cell in collagen diseases].
    Yamamoto K
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Feb; 18(1):1-13. PubMed ID: 7553029
    [No Abstract]   [Full Text] [Related]  

  • 11. [Incidence of anti-melitensis antibodies (complete and incomplete) in healthy subjects and in various diseases].
    Tedesco F; Liso V; Bonomo L
    Boll Soc Ital Biol Sper; 1968 Sep; 44(18):1545-7. PubMed ID: 5732929
    [No Abstract]   [Full Text] [Related]  

  • 12. Heterogeneity of cold- and warm-reacting cytotoxins against lymphocytes, granulocytes, and monocytes in rheumatic diseases.
    Pruzanski W; Armstrong M; Urowitz MB
    Clin Immunol Immunopathol; 1978 Oct; 11(2):142-56. PubMed ID: 737913
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunohistochemical research in diffuse reactive mesenchymopathies. Results and interpretative speculations].
    Grimaldi MG
    Recenti Prog Med; 1969 Feb; 46(2):133-69. PubMed ID: 4893918
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocytotoxins in lupus erythematosus.
    Shaw JF
    Ala J Med Sci; 1971 Apr; 8(2):210-4. PubMed ID: 5096772
    [No Abstract]   [Full Text] [Related]  

  • 15. [Surface markers of peripheral blood T- and B-lymphocytes in patients with rheumatoid diseases].
    Stankaitene DI; Redaitene EI; Rulis AK; Ianulevichiute NA
    Ter Arkh; 1981; 53(7):6-11. PubMed ID: 7027511
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibodies to extractable nuclear antigens in rheumatic diseases].
    Ivanova SM; Ivanova MM; Speranskiĭ AI
    Ter Arkh; 1980; 52(6):59-62. PubMed ID: 7404390
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulating antibody-antigen complexes in human disease: possible occurrence in cancer.
    Schrohenloher RE; Volanakis JE
    Ala J Med Sci; 1977 Jan; 14(1):10-20. PubMed ID: 322524
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antibodies against the human immunodeficiency virus in patients with systemic lupus erythematosus and other collagen-vascular diseases].
    Alonso Pérez A; Hernández Márquez S; Gómez Trujillo F; de Ramón Garrido E
    Med Clin (Barc); 1987 Dec; 89(20):883. PubMed ID: 3482295
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on B cell activation in collagenoses].
    Becker H; Schauer U; Helmke K
    Immun Infekt; 1985 Apr; 13(2):78-9. PubMed ID: 3873397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunologic research in the course of several collagenoses in childhood. Evaluation of results from the diagnostic angle].
    Burgio GR; Vaccaro R
    Schweiz Rundsch Med Prax; 1970 Jan; 59(3):75-9. PubMed ID: 4932445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.